• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注意缺陷多动障碍儿童课前功能量表的信度和效度。

Reliability and Validity of the Before-School Functioning Scale in Children With ADHD.

机构信息

1 State University of New York Upstate Medical University, Syracuse, USA.

2 Massachusetts General Hospital, Boston, USA.

出版信息

J Atten Disord. 2018 Sep;22(11):1040-1048. doi: 10.1177/1087054714564623. Epub 2015 Jan 9.

DOI:10.1177/1087054714564623
PMID:25575616
Abstract

OBJECTIVE

Children with ADHD frequently manifest behavioral difficulties in the morning prior to school. We sought to assess the reliability and validity of the Before-School Functioning Questionnaire (BSFQ) as a measure of morning behaviors impaired by ADHD.

METHOD

We used pre-treatment data from a randomized crossover study of 6- to 12-year-old participants comparing the methylphenidate transdermal delivery system (MTS) with a placebo transdermal system (PTS) for a total of 4 weeks.

RESULTS

The BSFQ investigator-rated scale shows very good internal homogeneity (Cronbach's α = .91), good test-retest reliability ( r = .60), good concurrent validity ( r range = .42-.86), and a strong treatment effect (effect size = -.93). The self-rated BSFQ showed lower levels of reliability and validity.

CONCLUSION

The investigator-rated BSFQ should be used in future trials of ADHD medications aimed at assessing efficacy in the morning before school.

摘要

目的

患有注意缺陷多动障碍(ADHD)的儿童在上学前的早晨经常表现出行为困难。我们试图评估在学校前功能问卷(BSFQ)作为评估 ADHD 导致的早晨行为障碍的测量工具的可靠性和有效性。

方法

我们使用了一项随机交叉研究的治疗前数据,该研究比较了 6 至 12 岁参与者的哌醋甲酯透皮输送系统(MTS)与安慰剂透皮系统(PTS)的治疗效果,共进行了 4 周。

结果

BSFQ 研究者评定量表显示出非常好的内部同质性(Cronbach's α =.91),良好的重测信度( r =.60),良好的同时效度( r 范围为.42-.86),以及很强的治疗效果(效应量 = -.93)。自我报告的 BSFQ 显示出较低的可靠性和有效性。

结论

在评估 ADHD 药物在上学前早晨的疗效的未来临床试验中,应使用研究者评定的 BSFQ。

相似文献

1
Reliability and Validity of the Before-School Functioning Scale in Children With ADHD.注意缺陷多动障碍儿童课前功能量表的信度和效度。
J Atten Disord. 2018 Sep;22(11):1040-1048. doi: 10.1177/1087054714564623. Epub 2015 Jan 9.
2
A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.一项关于哌醋甲酯透皮贴剂对注意缺陷多动障碍儿童上学前功能影响的对照试验。
J Clin Psychiatry. 2010 May;71(5):548-56. doi: 10.4088/JCP.09m05779pur.
3
Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.《晚间和晨间行为日常父母评定量表修订版的信度和效度》。
J Atten Disord. 2018 Sep;22(11):1066-1073. doi: 10.1177/1087054715619009. Epub 2015 Dec 23.
4
Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.缓释和长效释放型哌甲酯(HLD200)治疗注意缺陷/多动障碍儿童的疗效与安全性
J Child Adolesc Psychopharmacol. 2017 Aug;27(6):474-482. doi: 10.1089/cap.2017.0084. Epub 2017 Jul 21.
5
OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.奥罗莫苯丙胺对 ADHD 成人特定执行功能缺陷的疗效:一项随机、安慰剂对照交叉研究。
Eur Neuropsychopharmacol. 2014 Apr;24(4):519-28. doi: 10.1016/j.euroneuro.2014.01.007. Epub 2014 Jan 18.
6
Functional Impairment in Youth With ADHD: Normative Data and Norm-Referenced Cutoff Points for the Before School Functioning Questionnaire and the Parent Rating of Evening and Morning Behavior Scale, Revised.注意缺陷多动障碍青少年的功能障碍:上学前功能问卷和父母评定的夜间和清晨行为量表修订版的常模数据和常模参照截断值。
J Clin Psychiatry. 2019 Dec 10;81(1):19m12956. doi: 10.4088/JCP.19m12956.
7
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.一项关于哌甲酯透皮系统治疗小儿注意力缺陷/多动障碍的随机、双盲、安慰剂对照平行组研究。
J Clin Psychiatry. 2008 Jan;69(1):149-59. doi: 10.4088/jcp.v69n0120.
8
Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder: an open-label study.渗透型释放口崩型哌甲酯治疗注意缺陷多动障碍青少年学习技能的效果:一项开放性研究。
Int Clin Psychopharmacol. 2013 Jul;28(4):184-92. doi: 10.1097/YIC.0b013e3283612509.
9
Morning and Evening Effects of Guanfacine Extended Release Adjunctive to Psychostimulants in Pediatric ADHD.胍法辛缓释剂辅助精神兴奋剂治疗小儿多动症的早晚效应
J Atten Disord. 2017 Jan;21(2):110-119. doi: 10.1177/1087054713500144. Epub 2016 Jul 28.
10
HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.ADHD 患儿接受哌醋甲酯透皮贴剂治疗后的 HRQL 和药物满意度。
Curr Med Res Opin. 2009 Dec;25(12):3001-10. doi: 10.1185/03007990903388797.

引用本文的文献

1
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
2
Clinically Meaningful Improvements in Early Morning and Late Afternoon/Evening Functional Impairment in Children with ADHD Treated with Delayed-Release and Extended-Release Methylphenidate.接受延迟释放和缓释哌甲酯治疗的 ADHD 儿童在清晨和傍晚/晚间的功能障碍方面有临床意义上的改善。
J Atten Disord. 2022 Mar;26(5):696-705. doi: 10.1177/10870547211020073. Epub 2021 Jun 4.
3
Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder.
延迟释放和延长释放哌甲酯对照顾者负担的影响及照顾者负担问卷心理测量学特性的验证:来自儿童注意缺陷多动障碍 3 期试验的结果。
J Child Adolesc Psychopharmacol. 2021 Apr;31(3):179-186. doi: 10.1089/cap.2020.0159. Epub 2021 Apr 1.
4
A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.一项随机、双盲、安慰剂对照研究评估 HLD200(一种控释和缓释哌甲酯)治疗注意缺陷多动障碍儿童的安全性和疗效:全天和跨环境的评估。
J Child Adolesc Psychopharmacol. 2020 Feb;30(1):2-14. doi: 10.1089/cap.2019.0070. Epub 2019 Aug 29.
5
Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.缓释和长效释放型哌甲酯(HLD200)治疗注意缺陷/多动障碍儿童的疗效与安全性
J Child Adolesc Psychopharmacol. 2017 Aug;27(6):474-482. doi: 10.1089/cap.2017.0084. Epub 2017 Jul 21.
6
Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family.与对照组相比,接受兴奋剂治疗的注意力缺陷/多动障碍儿童的清晨功能损害:对家庭的影响。
J Child Adolesc Psychopharmacol. 2017 Oct;27(8):715-722. doi: 10.1089/cap.2016.0164. Epub 2017 Apr 10.
7
Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers.使用兴奋剂治疗的注意缺陷/多动障碍儿童和青少年的清晨功能及其对照顾者的影响。
J Child Adolesc Psychopharmacol. 2015 Sep;25(7):558-65. doi: 10.1089/cap.2014.0160. Epub 2015 Jul 7.